<style face="normal" font="default" size="100%">Lower Risk of CV Events and Death Associated with Initiation of SGLT2 vs. DPP-4 Inhibitors-Analysis from the CVD-REAL 2 Study</style>

Drupal-Bibcite

31<style face="normal" font="default" size="100%">Lower Risk of CV Events and Death Associated with Initiation of SGLT2 vs. DPP-4 Inhibitors-Analysis from the CVD-REAL 2 Study</style><style face="normal" font="default" size="100%">Lower Risk of CV Events and Death Associated with Initiation of SGLT2 vs. DPP-4 Inhibitors-Analysis from the CVD-REAL 2 Study</style>